Nearly 30 million people in the US have diabetes; another 3 million in the UK have the disease. People with diabetes often need to monitor their blood sugar levels. Although glucose meters are widely used for taking blood sugar readings, a new range of devices that continuously track blood sugar levels are becoming popular in the market. Known as continuous glucose monitor (CGM), these devices collect readings every few minutes and displays the result to the user.
Trends in the Continuous Glucose Monitoring Devices Market
Demand for CGM has been growing at a steady pace owing to the rising diabetes levels in the world. These devices are predominantly bought by patients, who in the past, have experienced dangerously low or high blood sugar levels. CGMs are equipped with a transmitter and monitor, and the latter sets off an alarm if the blood sugar levels drop to dangerous levels.
CGMs are proving to be effective medical devices for managing diabetes. In addition to constantly updating the patients about their blood sugar levels, CGMs help doctors see trends or patterns that are useful in prescribing the insulin levels and the appropriate medication.
Demand for CGMs is strong from at-home patients, as well as hospitals. However, owing to the simplicity of the device and requirement for advanced systems in hospitals, households account for the bulk of the demand for CGMs. The global market for CGMs is anticipated to reach US$ 788.4 Mn in 2020, out of which, households are expected to account for US$ 275 Mn.
Although people with diabetes are the target audience for CGM companies, the healthcare community advises that everyone should keep track of their blood glucose levels. Abnormal blood sugar levels can lead a host of health risks, including obesity, cardiovascular disease, and mood swings.
Keep track of blood sugar levels can help prevent pre-diabetes from developing into type 2 diabetes. In many people, blood sugar levels are higher than normal, but not high enough to be classified as type 2 diabetes. As the pre-diabetes remains undiagnosed due to ignorance about blood sugar levels, it slowly develops into type 2 diabetes. CGMs that monitor blood sugar levels continuously can of utmost benefit in these scenarios.
Obesity has become an epidemic globally. Although a number of factors play a role in obesity, eating foods high in sugar is one of the causes. Many times people are simply unaware as to why they get those sudden cravings for chocolates and candies. It is due to the falling glucose levels in the body that transmit the signals to the brain and causes us to binge on sugary food.
Using CGMs to track blood sugar levels continuously can help in keeping the weight in check. It can also help in early diagnosis of both type 1 and type 2 diabetes.
High cost remains a challenge for the widespread popularity of continuous glucose monitoring systems. However, technological innovation is expected to bring down the cost in the future, and it is expected that more people will buy these devices.
Medtronic, Dexcom, Abott are some of the key players that manufacture continuous glucose monitoring devices. Among these, the devices from Medtronic are popular among consumers.
High awareness among consumers in North America make it one of the most lucrative markets for continuous glucose monitoring devices. Although awareness among consumers is low in Asia Pacific, owing to the high population in the region, high volume sales of CGMs is expected.
Browse Full: "Continuous Glucose Monitoring Systems Market: Global Industry Analysis and Opportunity Assessment 2015 - 2020" Market Research Report at http://www.futuremarketinsights.com/reports/details/continuous-glucose-monitoring-systems-market
The Freeze Thaw System Market is segmented by Product Type (freeze-thaw modular platforms, controlled rate chambers, single-use bags, and shippers), Application (R&D, pre-clinical & clinical, and commercial), End User (academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and contract manufacturing organizations), and Region. Forecast for 2026 to 2036.
The Compounding Pharmacies Market is segmented by Product (oral medication, topical medication, mouthwashes, and suppositories), Application (medication for adults, medication for veterinary, medication for children, and medication for geriatric), Therapeutic Area (pain management, hormone replacement therapy, and others), and Region. Forecast for 2026 to 2036.
The Urban Pharma Micro-Depot and Delivery Network market is segmented by network model (dark-store depots, partner pharmacies, hospital satellites, hybrid hubs), delivery speed (same-day, two-hour, scheduled, next-day), temperature band (ambient, cold chain, controlled room), order type (chronic refills, acute Rx, OTC add-ons, specialty Rx), end user (retail chains, digital pharmacies, hospitals, clinic groups), and Region. Forecast for 2026 to 2036.
The high-value healthcare asset tracking and recovery platforms market is segmented by Technology (BLE, RFID, UWB, Wi-Fi), Deployment (Cloud, Hybrid, On-premise), Asset Class (Infusion pumps, Ventilators, Monitors, Wheelchairs, Imaging carts), End User (Hospitals, Health systems, ASCs, Clinics), Component (Software, Tags, Readers, Services), and Region. Forecast for 2026 to 2036.
The Post-Acute Transition Care Coordination Platform Market Is Segmented By Deployment (Cloud, On-Premise, Hybrid), Module (Referral Management, Discharge Planning, Network Management, Authorization, Analytics), Care-Setting (Hospitals, SNFs, Home Health, Rehab Centers, ACOs), End User (Providers, Payers, Health Systems, Community Networks), Transition Type (Hospital-To-SNF, Hospital-To-Home, Hospital-To-Rehab, SNF-To-Home, Cross-Setting Follow-Up), And Region. Forecast For 2026 To 2036.